PEG
50
4
ADM
16
-9
CFG
58
6
MPC
31
5
SLG
66
4
PNW
66
3
NKE
30
2
PYPL
41
2
M
30
2
TRV
48
2
PFE
21
-2
DGX
36
3
DUK
37
2
CMS
57
3
CNP
44
5
ROST
57
3
NTRS
54
4
CINF
40
5
BA
48
-5
V
56
2
PEG
50
4
ADM
16
-9
CFG
58
6
MPC
31
5
SLG
66
4
PNW
66
3
NKE
30
2
PYPL
41
2
M
30
2
TRV
48
2
PFE
21
-2
DGX
36
3
DUK
37
2
CMS
57
3
CNP
44
5
ROST
57
3
NTRS
54
4
CINF
40
5
BA
48
-5
V
56
2
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
51

VRNA
Verona Pharma PLC

Last Price:
38.47
Seasonality Move:
15.78%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Verona Pharma PLC Price Quote

$38.47
+0.08 (+0.76%)
(Updated: November 6, 2024 at 4:12 AM ET)

Verona Pharma PLC Key Stats

Buy
51
Verona Pharma PLC (VRNA) is a Buy
Day range:
$37.80 - $39.40
52-week range:
$11.39 - $39.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
24.07%
Volume:
1.2M
Avg. volume:
1M
1-year change:
149.77%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-2

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

  • How Much Debt Does Verona Pharma PLC Have?
    Total long term debt quarterly is $120M
  • How Much Cash Does Verona Pharma PLC Have?
    Cash and short term investments quarterly total is $336M
  • What Is Verona Pharma PLC’s Book Value Per Share?
    Book value per share is 1.59

Is Verona Pharma PLC Cash Flow Positive?

  • What Is VRNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$103.8M
  • What Is Verona Pharma PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $180.6M
  • What Is Verona Pharma PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$45K

Verona Pharma PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    VRNA return on invested capital is -55.17%
  • What Is Verona Pharma PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -45.04%
  • What Is VRNA Return On Equity?
    ROE is a measure of profitability and is -74.15%

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • NuCana PLC (NCNA)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -36.59%
Revenue: 0% 180.53%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 46.57
Upside from Last Price: 21.31%

Major Shareholders

  • How many VRNA shares are owned by institutional investors?
    87.5M VRNA shares are owned by institutional investors
  • How many VRNA shares are owned by insiders?
    42.2M VRNA shares are owned by insiders